Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment

Completed

• Conditions: Infertility

• Registration Number: NCT03607409
• Lead Sponsor: ART Fertility Clinics LLC

Brief Summary

To evaluate the role of Inhibin A as bio marker for the number of mature oocytes, compared to Estradiol

Detailed Description

Inhibin A could be an improved biomarker regarding the number of expected mature oocytes compared to estradiol.

Study Timeline

• Study First Submitted: 2018-07-23
• Study First Submitted QC: 2018-07-30
• Study First Posted: 2018-07-31
• Study Start: 2018-09-09
• Primary Completion: 2019-01-29
• Study Completion: 2019-07-04
• Status Verified: 2019-08
• Last Update Submitted: 2019-08-06
• Last Update Posted: 2019-08-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

Patients undergoing ovarian stimulation with gonadotropins in either a GnRH-agonist or GnRH-antagonist for IVF treatment due to primary / secondary infertility.

Exclusion Criteria

Patients undergoing a modified natural cycle stimulation protocol (Taymour cycle) Patients at risk for development of ovarian hyperstimulation syndrome (OHSS)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of mature oocytes	1 year	Patients undergoing ovarian stimulation with gonadotropins

Trial Locations

Locations (1)

IVI Middle East Fertilty Clinic; 🇦🇪 Abu Dhabi, United Arab Emirates